MENU
APR 28, 2017 6:00 AM PDT

Disseminated Intravascular Coagulation (DIC) and Thrombosis: The Critical Role of the Lab

Sponsored by: Diagnostica Stago, Inc.
Speaker
  • Scientific Business Development Manager, Diagnostica Stago, Inc.
    Biography
      Paul earned a PhD in biochemistry from Temple University in 2006, with the subject of the dissertation regarding the function of coagulation factor XI. He also did postdoctoral training in a related area before becoming a product manager and scientific affairs specialist in 2009. During his time at Stago, Paul also completed an MBA degree program at Cornell University in 2014. He has spoken to dozens of medical technologist, clinical laboratory scientist, pharmacist and clinician audiences about various topics within hemostasis and coagulation. He also has a great interest in working with clinical pathologists, pharmacists, basic scientists, and pharmaceutical researchers to perform studies and publish, contributing to advancement of the hemostasis and coagulation science.

    Abstract

    Disseminated Intravascular Coagulation (DIC) is a serious hypercoagulable disorder which can occur in hospitalized patients resulting in a high degree of morbidity and mortality.  DIC is a confusing disorder from both diagnostic and therapeutic standpoints resulting from several unrelated diseases which can trigger DIC, along with a lack of uniformity in clinical manifestation, laboratory diagnostic practices, and consensus on patient management.  The laboratory, by implementing the correct panel of testing methodologies, can greatly assist clinicians in patient management.  This lecture will describe the laboratory testing in order to illuminate this condition for people unfamiliar with the condition.

    Learning objectives:

    1. Describe the basic pathophysiology of DIC
    2. Demonstrate a diagnostic and management approach for DIC
    3. Compare markers of thrombin & plasmin generation in DIC, including D-Dimer, Fibrin Monomers/soluble fibrin, and fibrin degradation products (FDPs)
    4. Correlate DIC theory and testing to specific clinical case

     


    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    Loading Comments...
    Show Resources
    Attendees
    • See more